Sabra Health Care REIT Stock Forecast, Price & News

$15.79
-0.08 (-0.50 %)
(As of 09/17/2021 12:00 AM ET)
Add
Compare
Today's Range
$15.68
$15.96
50-Day Range
$15.40
$18.68
52-Week Range
$12.86
$19.01
Volume2.83 million shs
Average Volume1.77 million shs
Market Capitalization$3.49 billion
P/E RatioN/A
Dividend Yield7.56%
Beta1.5
30 days | 90 days | 365 days | Advanced Chart
Receive SBRA News and Ratings via Email

Sign-up to receive the latest news and ratings for Sabra Health Care REIT and its competitors with MarketBeat's FREE daily newsletter.


Sabra Health Care REIT logo

About Sabra Health Care REIT

Sabra Health Care REIT, Inc. engages in managing and investing in healthcare-related real estate properties. It focuses on the acquisition, financing and owning real estate property to be leased to third party tenants in the healthcare sector. The company was founded on May 10, 2010 and is headquartered in Irvine, CA.

Headlines

See More Headlines

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous

Social Links


MarketRank

Overall MarketRank

2.56 out of 5 stars

Finance Sector

171st out of 1,330 stocks

Real Estate Investment Trusts Industry

28th out of 219 stocks

Analyst Opinion: 2.4Community Rank: 4.1Dividend Strength: 3.3Insider Behavior: 1.7Valuation: 1.3 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles











Sabra Health Care REIT (NASDAQ:SBRA) Frequently Asked Questions

Is Sabra Health Care REIT a buy right now?

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Sabra Health Care REIT in the last twelve months. There are currently 1 hold rating and 4 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" Sabra Health Care REIT stock.
View analyst ratings for Sabra Health Care REIT
or view top-rated stocks.

What stocks does MarketBeat like better than Sabra Health Care REIT?

Wall Street analysts have given Sabra Health Care REIT a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Sabra Health Care REIT wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting Sabra Health Care REIT?

Sabra Health Care REIT saw a increase in short interest in August. As of August 31st, there was short interest totaling 4,460,000 shares, an increase of 21.5% from the August 15th total of 3,670,000 shares. Based on an average trading volume of 1,710,000 shares, the short-interest ratio is presently 2.6 days.
View Sabra Health Care REIT's Short Interest
.

When is Sabra Health Care REIT's next earnings date?

Sabra Health Care REIT is scheduled to release its next quarterly earnings announcement on Thursday, November 4th 2021.
View our earnings forecast for Sabra Health Care REIT
.

How were Sabra Health Care REIT's earnings last quarter?

Sabra Health Care REIT, Inc. (NASDAQ:SBRA) released its quarterly earnings results on Wednesday, August, 4th. The real estate investment trust reported ($0.61) earnings per share for the quarter, missing the Thomson Reuters' consensus estimate of $0.37 by $0.98. Sabra Health Care REIT had a negative trailing twelve-month return on equity of 0.75% and a negative net margin of 4.25%.
View Sabra Health Care REIT's earnings history
.

How has Sabra Health Care REIT's stock price been impacted by Coronavirus (COVID-19)?

Sabra Health Care REIT's stock was trading at $13.34 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, SBRA stock has increased by 18.4% and is now trading at $15.79.
View which stocks have been most impacted by COVID-19
.

How often does Sabra Health Care REIT pay dividends? What is the dividend yield for Sabra Health Care REIT?

Sabra Health Care REIT announced a quarterly dividend on Wednesday, August 4th. Investors of record on Tuesday, August 17th will be given a dividend of $0.30 per share on Tuesday, August 31st. This represents a $1.20 dividend on an annualized basis and a yield of 7.60%. The ex-dividend date of this dividend is Monday, August 16th.
View Sabra Health Care REIT's dividend history
.

Is Sabra Health Care REIT a good dividend stock?

Sabra Health Care REIT pays an annual dividend of $1.20 per share and currently has a dividend yield of 7.56%. SBRA has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. The dividend payout ratio of Sabra Health Care REIT is 68.97%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Sabra Health Care REIT will have a dividend payout ratio of 74.53% next year. This indicates that Sabra Health Care REIT will be able to sustain or increase its dividend.
View Sabra Health Care REIT's dividend history.

What guidance has Sabra Health Care REIT issued on next quarter's earnings?

Sabra Health Care REIT issued an update on its FY 2021 earnings guidance on Monday, September, 13th. The company provided earnings per share (EPS) guidance of $1.510-$1.530 for the period. The company issued revenue guidance of -.

What price target have analysts set for SBRA?

5 equities research analysts have issued 12-month price targets for Sabra Health Care REIT's shares. Their forecasts range from $17.00 to $21.00. On average, they anticipate Sabra Health Care REIT's stock price to reach $19.50 in the next twelve months. This suggests a possible upside of 23.5% from the stock's current price.
View analysts' price targets for Sabra Health Care REIT
or view top-rated stocks among Wall Street analysts.

Who are Sabra Health Care REIT's key executives?

Sabra Health Care REIT's management team includes the following people:
  • Rick Matros, Chairman, President & Chief Executive Officer
  • Harold Wayne Andrews, Chief Financial Officer, Secretary & Executive VP
  • Talya Nevo-Hacohen, Chief Investment Officer, Treasurer & Executive VP
  • Brent P. Chappell, Executive Vice President-Portfolio Management
  • Darrin Smith, Executive Vice President-Investments

Who are some of Sabra Health Care REIT's key competitors?

What other stocks do shareholders of Sabra Health Care REIT own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Sabra Health Care REIT investors own include AT&T (T), Omega Healthcare Investors (OHI), Realty Income (O), Medical Properties Trust (MPW), Energy Transfer (ET), Verizon Communications (VZ), Bank of America (BAC), Annaly Capital Management (NLY), Ventas (VTR) and New Residential Investment (NRZ).

What is Sabra Health Care REIT's stock symbol?

Sabra Health Care REIT trades on the NASDAQ under the ticker symbol "SBRA."

Who are Sabra Health Care REIT's major shareholders?

Sabra Health Care REIT's stock is owned by a number of retail and institutional investors. Top institutional shareholders include Vanguard Group Inc. (15.34%), BlackRock Inc. (14.39%), Principal Financial Group Inc. (6.44%), State Street Corp (3.93%), APG Asset Management US Inc. (2.80%) and Bank of New York Mellon Corp (2.64%). Company insiders that own Sabra Health Care REIT stock include Catherine Cusack, Michael J Foster, Richard K Matros and Robert A Ettl.
View institutional ownership trends for Sabra Health Care REIT
.

Which major investors are selling Sabra Health Care REIT stock?

SBRA stock was sold by a variety of institutional investors in the last quarter, including Deutsche Bank AG, Weiss Multi Strategy Advisers LLC, Russell Investments Group Ltd., Millennium Management LLC, Nuveen Asset Management LLC, FMR LLC, Balyasny Asset Management LLC, and RPG Investment Advisory LLC.
View insider buying and selling activity for Sabra Health Care REIT
or view top insider-selling stocks.

Which major investors are buying Sabra Health Care REIT stock?

SBRA stock was bought by a variety of institutional investors in the last quarter, including Lasalle Investment Management Securities LLC, Goldman Sachs Group Inc., Sumitomo Mitsui Trust Holdings Inc., Miller Howard Investments Inc. NY, Schonfeld Strategic Advisors LLC, Principal Financial Group Inc., Victory Capital Management Inc., and Vanguard Group Inc.. Company insiders that have bought Sabra Health Care REIT stock in the last two years include Catherine Cusack, and Michael J Foster.
View insider buying and selling activity for Sabra Health Care REIT
or or view top insider-buying stocks.

How do I buy shares of Sabra Health Care REIT?

Shares of SBRA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Sabra Health Care REIT's stock price today?

One share of SBRA stock can currently be purchased for approximately $15.79.

How much money does Sabra Health Care REIT make?

Sabra Health Care REIT has a market capitalization of $3.49 billion and generates $598.57 million in revenue each year. The real estate investment trust earns $138.42 million in net income (profit) each year or $1.74 on an earnings per share basis.

How many employees does Sabra Health Care REIT have?

Sabra Health Care REIT employs 38 workers across the globe.

What is Sabra Health Care REIT's official website?

The official website for Sabra Health Care REIT is www.sabrahealth.com.

Where are Sabra Health Care REIT's headquarters?

Sabra Health Care REIT is headquartered at 18500 VON KARMAN AVENUE SUITE 550, IRVINE CA, 92612.

How can I contact Sabra Health Care REIT?

Sabra Health Care REIT's mailing address is 18500 VON KARMAN AVENUE SUITE 550, IRVINE CA, 92612. The real estate investment trust can be reached via phone at (888) 393-8248 or via email at [email protected].


This page was last updated on 9/19/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.